Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors
2006 ◽
Vol 20
(3)
◽
pp. 369-373
◽
2007 ◽
Vol 21
(2)
◽
pp. 166-171
◽
1997 ◽
Vol 29
(6)
◽
pp. 2677-2679
◽
2003 ◽
Vol 35
(2)
◽
pp. 609-611
◽